The Epidemiology Prevalence Rate and Surveillance Performance of Hospital-acquired Infections in Medical Department at Nopparat Rajathanee Hospital
Keywords:
Prevalence rate, Surveillance performance, Hospital-acquired infectionAbstract
Background : Hospital-acquired infections (HAI) are significantly associated with morbidity and mortality. HAI can be preventable through the strict surveillance program, but the causes, prevalence of HAI should be firstly investigated in order to establish the surveillance program more efficiently. Objective: This research had twoobjectives : 1) to survey a prevalence of hospital-acquired infection, and 2) to examine the performance of the surveillance program using in the Medical Department at Nopparat Rajathanee Hospital.Methods : This study was a cross-sectional survey which collected data retrospectively from May 31 to June 30, 2018 in 8 wards under the Medical Department. Participants were patients who were admitted to the 8 wards more than 2 calendar days. Data were collected by infection control nurses and infection control ward nurses using the infection surveillance form 1 of Nopparat Rajathanee Hospital. The prevalence rate and the surveillance program were analyzed using descriptive statistics.Results : the prevalence rate was 5.3%, the top three units with highest prevalence rate of HAI were the female semi ICU (10.3%), the Medical Intensive Care Unit (MICU) (9.3%), and the Medical VIP ward (9.1%). The hospital-acquired pneumonia (HAP) was the most common nosocomial infection which accounted for 30.6%. The second and third common nosocomial infection were the catheter associated urinary tract infection (26.5%) and the urinary tract infection (16.3%). The surveillance program performance was 85.7%.Conclusion : The epidemiology of hospital-acquired infection in Medical Department at Nopparat Rajathanee Hospital. Classified by pathogens were hospital-acquired pneumonia (HAP) occurred with A.baumannii MDR (25%) E.coli and K. pneumonia (16.7%). The catheter associated urinary tract infection from E.faecalis, C.tropicalis (20%) and the urinary tract infection from E.faecium, E.coli (28.6%). The prevalence rate of HAI of the study (5.3%). The surveillance effectiveness of the study (85.7%) was hight for prevention and infection control.
References
Russo PL, Stewardson AJ, Cheng AC, Bucknall T, Mitchell BG.The prevalence of healthcare associated infections among adult inpatients at nineteen large Australian acute-care public hospitals: a point prevalence survey.Antimicrob Resist Infect Control 2019;8:114.
Petersen MH, Holm MO, Pedersen SS, Lassen AT, Pedersen C.Incidence and prevalence of hospital-acquired infections in a cohort of patients admitted to medical department. Dan Med Bull 2010;57:A4210.
Aumprasert T. Prevalence of Hospital Acquired Infections Survey at Queen Sirikit National Institute of Child Health 2015. Journal of the Department of Medical Services 2017;42:6.
Infection Control Committee, Nopparat Rajathanee Hospital.Infection surveillance report in Hospital; 2004.
Unahalekhaka A. Epidemiology and Evidence-Based Practice Guideline in Prevention of Hospital-Associated Infection. ChiangMai: Mingmuangnavarat Company LTD; 2013 (in Thai).
Unahalekhaka A. Prevention of Nosocomial Infection : Principles and Guidelines; 2012.
Unahalekhaka A. Nosocomial Infection Surveillance; 1997.
Labi AK, Obeng-Nkrumah N, Owusu E, Bjerrum S, Bediako-Bowan A, Sunkwa-Mills G, et al. Multi-centre point--prevalence survey of hospital-acquired infections in Ghana. J Hosp Infect 2019;101:60-8.
Wu YL, Yang XY, Pan MS, Li RJ, Hu XQ, Zhang JJ, et al. An 8-year point-prevalence surveillance of healthcare-associated infections and antimicrobial use in a tertiary care teaching hospital in China. Epidemiol Infect 2018;147: 1-6.
Van Mourik MSM, Perencevich EN, Gastmeier P, Bonten MJM.Designing Surveillance of Healthcare-Associated Infections in the Era of Automation and Reporting Mandates. Clin Infect Dis 2018;66:970-6.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของกรมการแพทย์ กระทรวงสาธารณสุข
ข้อความและข้อคิดเห็นต่างๆ เป็นของผู้เขียนบทความ ไม่ใช่ความเห็นของกองบรรณาธิการหรือของวารสารกรมการแพทย์